U.S. orders antiviral drugs worth $138 million from SIGA Tech
(Reuters) – SIGA Technologies Inc on Thursday said it has won a new contract for its antiviral drug, Tpoxx, from the U.S. Department of Health …
(Reuters) – SIGA Technologies Inc on Thursday said it has won a new contract for its antiviral drug, Tpoxx, from the U.S. Department of Health …
(Reuters) – The National Institutes of Health (NIH) said on Friday it had started enrolling monkeypox patients in a late-stage study testing Siga Technologies Inc’s …
– Gilead Sciences Inc’s drug, remdesivir, showed antiviral activity against Omicron, Delta and other variants of the coronavirus in laboratory studies, the company said on …
-British researchers want to repurpose existing antiviral therapies to treat COVID-19, the University of Oxford said on Friday, in an attempt to sidestep lengthy development …
The New York State Department of Health (NYS DOH) is requiring healthcare providers to prioritize non-white patients when administering oral antiviral treatment for COVID-19. The …